[HTML][HTML] Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg
G Tepe, T Zeller, T Albrecht, S Heller… - … England Journal of …, 2008 - Mass Medical Soc
Background Drug-eluting stents reduce restenosis in coronary arteries, but clinical trials
have failed to prove their efficacy in peripheral arteries. We investigated the use of paclitaxel-…
have failed to prove their efficacy in peripheral arteries. We investigated the use of paclitaxel-…
[HTML][HTML] Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular …
…, J Roether, M Sprynger, M Tendera, G Tepe… - European Journal of …, 2018 - ejves.com
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno, Antonio
Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini, Stavros …
Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini, Stavros …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background— Drug-coated balloons (DCBs) have shown promise in improving the outcomes
for patients with peripheral artery disease. We compared a paclitaxel-coated balloon with …
for patients with peripheral artery disease. We compared a paclitaxel-coated balloon with …
Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial …
…, KL Schulte, E Minar, P Peeters, M Bosiers, G Tepe… - Circulation, 2007 - Am Heart Assoc
Background— Endoluminal treatment of superficial femoral artery lesions is a matter of
controversy. The present study was designed to investigate the impact of nitinol stenting of …
controversy. The present study was designed to investigate the impact of nitinol stenting of …
Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial
…, S Langner, B Reinkensmeier, HF Boettcher, G Tepe… - Circulation, 2008 - Am Heart Assoc
Background— The success of percutaneous intervention in peripheral arterial disease is
limited by restenosis. The aim of the present pilot study was to evaluate a novel method of local …
limited by restenosis. The aim of the present pilot study was to evaluate a novel method of local …
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial
…, J Anderson, B Wiesinger, G Tepe… - Journal of …, 2006 - journals.sagepub.com
Purpose: To review clinical outcomes of patients with chronic limb ischemia and TASC type
C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents. …
C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents. …
Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial
…, A Tielbeek, J Anderson, B Wiesinger, G Tepe… - Journal of Vascular and …, 2005 - Elsevier
PURPOSE: To investigate further the safety and efficacy of the sirolimus-eluting SMART
Nitinol Self-expanding Stent by comparison with a bare stent in superficial femoral artery (SFA) …
Nitinol Self-expanding Stent by comparison with a bare stent in superficial femoral artery (SFA) …
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized …
…, H Krankenberg, J Ricke, M Bosiers, G Tepe… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives : This study sought to evaluate the safety and efficacy of the Lutonix drug-coated
balloon (DCB) coated with 2 μg/mm 2 paclitaxel and a polysorbate/sorbitol carrier for …
balloon (DCB) coated with 2 μg/mm 2 paclitaxel and a polysorbate/sorbitol carrier for …
Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA
JR Laird, PA Schneider, G Tepe, M Brodmann… - Journal of the American …, 2015 - jacc.org
Background : Evidence from large, randomized, controlled peripheral artery disease trials
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical …
…, HB Smouse, SA Snyder, EE O'Leary, G Tepe… - Journal of the American …, 2013 - jacc.org
Objectives : A prospective, multinational randomized controlled trial (RCT) and a complementary
single-arm study evaluated the 2-year safety and effectiveness of a paclitaxel-coated …
single-arm study evaluated the 2-year safety and effectiveness of a paclitaxel-coated …